$BCRX News Article - BioCryst Presents New Long-term and Real-world Data Demonstrating Sustained Reductions in Hereditary Angioedema Attack Rates and Improvement in Quality of Life with ORLADEYO  (berotralstat) 
https://marketwirenews.com/news-releases/bioc...10548.html